{
    "code": "02024430",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024430",
    "time": "2023-11-09 22:53:41",
    "許可證字號": "衛署藥輸字第024430號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/04\/11",
    "發證\/登錄日期": "95\/04\/11",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202443001",
    "中文品名": "憶思能口服溶液",
    "英文品名": "Exelon oral solution",
    "適應症": "輕度至中度阿滋海默型失智症。\r\n與帕金森氏症相關的輕度至中度失智症。",
    "劑型": "170內服液劑",
    "包裝": "4000毫升以下玻璃瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "RIVASTIGMINE HYDROGEN TARTRATE",
    "限制項目": "02輸　入",
    "申請商名稱": "台灣諾華股份有限公司",
    "申請商地址": "臺北市中山區民生東路3段2號8樓",
    "主製造廠": [
        {
            "製造廠名稱": "DELPHARM HUNINGUE SAS",
            "製造廠廠址": "26 RUE DE LA CHAPELLE, 68330 HUNUNGUE, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "NOVARTIS PHARMA AG",
            "製造廠廠址": "LICHTSTRASSE 35, CH-4056 BASEL, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1204001410",
            "成分名稱": "RIVASTIGMINE HYDROGEN TARTRATE",
            "含量描述": "",
            "含量": "3.2000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "024430_Exelon oral solution-108-06-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024430&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "024430憶思能口服溶液-108-12-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024430&Seq=003&Type=9"
        },
        {
            "title": "020244300004.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024430&Seq=004&Type=8"
        }
    ]
}